RELIANCE ENDOSCOPE PROCESSING SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-04-15 for RELIANCE ENDOSCOPE PROCESSING SYSTEM manufactured by Steris Canada Corporation.

Event Text Entries

[43444194] The facility reported the employee's face appeared red and she appeared disoriented and confused while working with the eps unit. A steris service technician arrived at the facility, inspected the unit, and found the unit was experiencing low boot pressure alarms; which caused the cycles to abort. The cause of the boot pressure alarms could not be determined through the technician's inspection. The technician replaced the unit's control handle boot, ran a test cycle, and confirmed the unit was operating according to specification. It is unclear how the employee could have been exposed to any of the chemicals used with the eps. The operator manual (1-1) states, "in an emergency, stop cycle by pressing stop touch pad twice to abort cycle. Wait for processor to complete abort sequence. Wear appropriate personal protective equipment (ppe) when reaching into chamber. " in addition, (1-2) states, "before opening processor door manually, wear appropriate personal protective equipment (ppe). Allow processor to cool down. Avoid inhaling fumes from chamber and contact with any remaining solution. " an individual from steris service engineering will travel to the user facility's account for further evaluation and trouble shooting on the unit. In addition, a formal in-service training will be provided for the user facility staff. The investigation of this event is currently in process. A follow-up report will be submitted once additional information becomes available.
Patient Sequence No: 1, Text Type: N, H10


[43444195] The facility reported an employee exhibited signs of irritation while working with the reliance eps. The employee was escorted to the employee health department and resumed normal work duties the following week.
Patient Sequence No: 1, Text Type: D, B5


[47418596] On april 21, 2016, an individual from steris service engineering arrived at the user facility's account for further evaluation of the reliance eps unit. The inspection did not reveal any issues with the reliance eps unit that would have resulted in the irritation reported by the customer. The unit is operational and safe for use. In-service training was scheduled with the customer on (b)(6) 2016, however the customer cancelled the in-service and has not rescheduled with steris. No further issues have been reported by the customer.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9680353-2016-00040
MDR Report Key5582593
Date Received2016-04-15
Date of Report2016-04-15
Date of Event2016-03-18
Date Mfgr Received2016-03-18
Date Added to Maude2016-04-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. KATHRYN CADORETTE
Manufacturer Street5960 HEISLEY ROAD
Manufacturer CityMENTOR OH 44060
Manufacturer CountryUS
Manufacturer Postal44060
Manufacturer Phone4403927231
Manufacturer G1STERIS CANADA CORPORATION
Manufacturer Street490 ARMAND-PARIS
Manufacturer CityQUEBEC, QUEBEC GIC 8A3
Manufacturer CountryCA
Manufacturer Postal CodeGIC 8A3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameRELIANCE ENDOSCOPE PROCESSING SYSTEM
Generic NamePROCESSING SYSTEM
Product CodeNZA
Date Received2016-04-15
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerSTERIS CANADA CORPORATION
Manufacturer Address490 ARMAND-PARIS QUEBEC, QUEBEC GIC 8A3 CA GIC 8A3


Patients

Patient NumberTreatmentOutcomeDate
10 2016-04-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.